Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes
article
OA: gold
CC0
⤵ 9 in-corpus citations
Abstract
OBJECTIVES: Endometrioid carcinoma of the ovary is one of the most types of epithelial ovarian cancer associated to endometrioisis. Endometrioid tumors as well as endometriotic implants are characterized by the presence of epithelial cells, stromal cells, or a combination of booth, that resemble the endometrial cells, suggesting a possible endometrial origin of these tumors. Pro-inflammatory cytokines, including interleukin-1 (IL-1) have been reported to be involved in both endometriosis and ovarian carcinogenesis. The major objective of this study was to determine the level expression of IL-1 ligands system (IL-1alpha, IL-1beta and IL-1RA) in the most common subtypes of ovarian cancer cells compared to endometrial cells. METHODS: We used primary endometrial cells, endometrial cell line RL-952 and different subtypes of epithelial ovarian cancer cell lines including TOV-112D (endometrioid), TOV-21G (clear cell) and OV-90 (serous). Immunofluorescence and real-time PCR analysis were used respectively for detecting IL-1 ligands at the levels of cell-associated protein and mRNA. Soluble IL-1 ligands were analyzed by ELISA. RESULTS: We demonstrated that IL-1 ligands were expressed by all endometriosis-associated ovarian cancer subtypes and endometrial cells. In contrast to other cancer ovarian cells, endometrioid cells exhibit a specific decrease of cell-associated IL-1RA expression and its soluble secretion. CONCLUSION: Endometrioid ovarian cancer exhibits an alteration in the expression of IL-1RA, a key protector against tumorogenic effects of IL-1. This alteration evokes the same alteration observed in endometriotic cells in previous studies. This suggests a possible link between the endometrium, the tissue ectopic endometriosis and endometrioid ovarian cancer.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (58)
- Abnormal Interleukin-1 Receptor Type II Gene Expression in the Endometrium of Women with Endometriosis1 via openalex
- Angiogenic Factors in Endometriosis via openalex
- Association between endometriosis and cancer: A comprehensive review and a critical analysis of clinical and epidemiological evidence via openalex
- Characterization of human purified epithelial and stromal cells from endometrium and endometriosis in tissue culture via openalex
- Correlation Between Decreased Type‐II Interleukin‐1 Receptor and Increased Monocyte Chemotactic Protein‐1 Expression in the Endometrium of Women with Endometriosis via openalex
- Down-Regulation of Interleukin-1 Receptor Type 1 Expression Causes the Dysregulated Expression of CXC Chemokines in Endometriotic Stromal Cells: A Possible Mechanism for the Altered Immunological Functions in Endometriosis via openalex
- Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis via openalex
- Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions via openalex
- Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1 via openalex
- Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium via openalex
- Ovarian and extraovarian endometriosis-associated cancer via openalex
- Peritoneal fluid concentrations of interleukin-8 in patients with endometriosis depend on the severity of the disorder and are higher in the luteal phase via openalex
- Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology via openalex
- Steroid and cytokine regulation of matrix metalloproteinases and the pathophysiology of endometriosis. via openalex
- W2044227766 via openalex
- W2048270768 via openalex
- W2050019602 via openalex
- W2055943730 via openalex
- W2057321436 via openalex
- W2057684012 via openalex
- W2061081137 via openalex
- W2069740197 via openalex
- W2077065757 via openalex
- W2077937947 via openalex
- W2079110325 via openalex
- W2115871198 via openalex
- W2115954319 via openalex
- W2118085697 via openalex
- W2129355295 via openalex
- W2137049743 via openalex
- W2140276047 via openalex
- W2145158999 via openalex
- W2155709045 via openalex
- W2158494565 via openalex
- W2408554838 via openalex
- W2409491754 via openalex
- W2411029809 via openalex
- W2419227569 via openalex
- W2419774966 via openalex
- W3201778690 via openalex
- W4200531859 via openalex
- W4210987759 via openalex
- W4251502926 via openalex
- W67246124 via openalex
- W4323966335 via openalex
- W1480357432 via openalex
- W1520223434 via openalex
- W1587735651 via openalex
- W1945598588 via openalex
- W1965037168 via openalex
- W1977354546 via openalex
- W1978634856 via openalex
- W1999406693 via openalex
- W2006653423 via openalex
- W2006762288 via openalex
- W2028516288 via openalex
- W2037773213 via openalex
- W2043610446 via openalex
Cited by (9)
- The Expression of TGF-β1, SMAD3, ILK and miRNA-21 in the Ectopic and Eutopic Endometrium of Women with Endometriosis 2023
- Cytokine and growth factor profile in endometriosis: a multiplex analysis of peritoneal fluid to assess diagnostic utility 2020
- Endometriosis — insights into a multifaceted entity 2018
- Endometriosis: where are we and where are we going? 2016
- Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis 2015
- BMPR1B Up-Regulation via a miRNA Binding Site Variation Defines Endometriosis Susceptibility and CA125 Levels 2013
- Relationship between endometriosis and cancer from current perspective 2011
- Endometriosis and Ovarian Cancer: A Systematic Review 2011
- Clinicopathological characteristics of ovarian carcinomas associated with endometriosis 2011
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:18.915199+00:00
License: CC0
· commercial use OK